Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (371-380 of 421) with videos related to

Pageof 43
Sort By:
Surgical Endoscopy|June 17, 2026
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world studyKe Chen, Kai Zhang, Chunbing Zhu, et al.
Cancer Letters|February 9, 2016
ALDOA functions as an oncogene in the highly metastatic pancreatic cancerShunrong Ji, Bo Zhang, Jiang Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 19, 2026
Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEBZhiliang Wang, Di Wu, Yue Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 23, 2024
MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide ResistanceJunfeng Xu, Xin Lou, Fei Wang, et al.
Cancer Research|March 20, 2023
MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor ProgressionJunfeng Xu, Zeng Ye, Qifeng Zhuo, et al.
Cell Reports. Medicine|October 18, 2023
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-responseRong Tang, Jin Xu, Wei Wang, et al.
International Journal of Surgery (London, England)|February 24, 2026
Predictive model and novel classification of pancreatic fistula following minimally invasive enucleation: a prospective cohort study (CSPAC-MIEN-2)Ting Wang, Zheng Li, Yihua Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2016
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic CancerShunrong Ji, Yi Qin, Chen Liang, et al.
European Journal of Immunology|July 9, 2017
Human profilin 1 is a negative regulator of CTL mediated cell-killing and migrationRouven Schoppmeyer, Renping Zhao, He Cheng, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 23, 2018
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancerGuopei Luo, Zhiyao Fan, He Cheng, et al.
Pageof 43

Showing results (371-380 of 421) with videos related to

Sort By:
Pageof 43
Surgical Endoscopy|June 17, 2026
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world studyKe Chen, Kai Zhang, Chunbing Zhu, et al.
Cancer Letters|February 9, 2016
ALDOA functions as an oncogene in the highly metastatic pancreatic cancerShunrong Ji, Bo Zhang, Jiang Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 19, 2026
Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEBZhiliang Wang, Di Wu, Yue Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 23, 2024
MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide ResistanceJunfeng Xu, Xin Lou, Fei Wang, et al.
Cancer Research|March 20, 2023
MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor ProgressionJunfeng Xu, Zeng Ye, Qifeng Zhuo, et al.
Cell Reports. Medicine|October 18, 2023
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-responseRong Tang, Jin Xu, Wei Wang, et al.
International Journal of Surgery (London, England)|February 24, 2026
Predictive model and novel classification of pancreatic fistula following minimally invasive enucleation: a prospective cohort study (CSPAC-MIEN-2)Ting Wang, Zheng Li, Yihua Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2016
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic CancerShunrong Ji, Yi Qin, Chen Liang, et al.
European Journal of Immunology|July 9, 2017
Human profilin 1 is a negative regulator of CTL mediated cell-killing and migrationRouven Schoppmeyer, Renping Zhao, He Cheng, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 23, 2018
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancerGuopei Luo, Zhiyao Fan, He Cheng, et al.
Pageof 43